Somnetics International, Inc. Receives CE Mark for Transcend® CPAP Sleep Apnea Therapy

Share Article

Distribution of Transcend sleep apnea therapy CPAP expands to Europe and Canada

Transcend CPAP is changing the way sleep apnea therapy is delivered

"We are ready to meet the demand and are looking forward to expansion in these key markets."

Somnetics International, Inc., the Minneapolis-based maker of Transcend® Sleep Apnea Therapy System™ announced that it received CE Mark and will expand distribution of Transcend to Europe. In October 2011 Transcend received registration approval in Canada.

Transcend is the world’s smallest, lightest, and most portable continuous positive airway pressure (CPAP) and battery system. Somnetics recently introduced new options and accessories that make Transcend the industry’s most flexible CPAP system for hassle-free travel and home use.

Clarence Johnson, CEO and president of Somnetics International, Inc., said “We are pleased that Transcend has received the CE Mark certification in Europe and registration approval in Canada. We are ready to meet the demand and are looking forward to expansion in these key markets.”

“Our distribution is in place and we plan to move quickly into key European markets,” said Rischeh Kumarasinghe, senior vice president of international. “We have ramped up our sales and marketing support to meet international demand.”

Somnetics received FDA market clearance for the Transcend obstructive sleep apnea therapy device in July 2010. Since then, Somnetics has introduced waterless humidification, lightweight and portable battery systems and accessories to make this the smallest, lightest, most portable and most flexible CPAP and battery system available.

Somnetics sells its products through an established network of distributors and direct sales representatives serving markets across the U.S. and in key markets around the world.

For information about Transcend visit or call 877-621-9626.

About Somnetics International, Inc.
Somnetics International, Inc. is a privately-held medical device company based in Minneapolis, Minn. It is an emerging leader in customer-driven design, development and production of respiratory medical devices to treat sleep apnea and related issues. Somnetics’ mission is focused on integrating technology, customer input and employee creativity to provide innovative, high quality products that improve quality of life for people with respiratory disorders. Transcend received the Innovation Award at Medtrade in October 2011 and the 2012 Best Practices Award for Product Differentiation in the Sleep Disordered Breathing market from Frost & Sullivan. Somnetics received FDA market clearance for the Transcend CPAP machine in July 2010. Transcend and associated technology is protected by several issued and pending US and foreign patents.


Media Contact: Kathleen Crandall 612/327-6336 (kathleen(at)crandallcommunications(dot)com)

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Kathleen Crandall
Crandall Communications
Email >
Visit website